Skip to main content
Fig. 3 | Insights into Imaging

Fig. 3

From: Myocardial extracellular volume derived from contrast-enhanced chest computed tomography for longitudinal evaluation of cardiotoxicity in patients with breast cancer treated with anthracyclines

Fig. 3

The temporal changes and linear fitting of longitudinal changes of myocardial ECV of BC patients. CTRCD0, patients without cancer therapy-related cardiac dysfunction; CTRCD1, patients with cancer therapy-related cardiac dysfunction; ECV, myocardial extracellular volume; BC, breast cancer

Back to article page